Rate My Professor Julia Hippisley-Cox

Hippisley-Cox has pioneered numerous first-of-their-kind clinical risk prediction algorithms implemented at scale across the NHS, including QRISK for cardiovascular disease risk (2007), QRISK2 (2008), QRISK3 (2017), QFractureScores for osteoporotic fractures (2009), QDScore for type 2 diabetes (2009), and QCOVID for COVID-19 hospitalisation and mortality risk (2020), which expanded the shielded patient list and prioritised 1.5 million high-risk individuals for vaccination. These tools, alongside others on cancer risks and drug effects, have saved thousands of premature deaths from cardiovascular disease. She has undertaken national leadership roles, chairing the Risk Stratification Subgroup of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG), serving on Scientific Advisory Group for Emergencies (SAGE) subgroups, the Chief Medical Officer's screening advisory group, NHS Health Check Expert Panel, National Ethics and Confidentiality Committee, and as a founder member of the Confidentiality Advisory Group. Her honours include the Royal College of General Practitioners John Fry Award (2009), Florence Nightingale Award from the Royal Statistical Society (2021), HSJ Best Use of Technology Award, John Perry Award for NHS IT contributions (2013 and 2021), Fellowship of the Academy of Medical Sciences, and NIHR Senior Investigator status.